Please login to the form below

Not currently logged in
Email:
Password:

Kevzara

This page shows the latest Kevzara news and features for those working in and with pharma, biotech and healthcare.

Dupixent helps put Sanofi back on growth track

Dupixent helps put Sanofi back on growth track

Another Regeneron-partnered drug – Kevzara (sarilumab) for rheumatoid arthritis – continues to struggle however with glacial growth since its approval in the middle of last year, adding 22m in the third quarter,

Latest news

More from news
Approximately 3 fully matching, plus 10 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Jet Off with Maloff Protect

Latest intelligence

The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....
Escaping the spin cycle of sub-optimal launch
...

Infographics